Purchases and Sales Made in Q4 2023 in Revolution Medicines, Inc. (RVMD)
This table provides information about the institutional ownership of Revolution Medicines, Inc. (RVMD) during Q4 2023. The information is specifically focused on institutions that hold shares of Revolution Medicines, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-41.3K- 1.84% |
$757K - $1.41M
|
2.2M
$90.9M
|
|
|
Jan 12, 2024
Q4 2023
|
Sg Americas Securities, LLC
|
SELL
|
- |
-54.2K- 93.78% |
$995K - $1.85M
|
3.6K
$149K
|
|
|
Nov 14, 2024
Q4 2023
|
Neuberger Berman Group LLC
New York, NY |
SELL
|
- |
-56.3K- 39.63% |
$1.03M - $1.92M
|
85.8K
$3.55M
|
|
|
Feb 12, 2024
Q4 2023
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-76.6K- 37.28% |
$1.41M - $2.61M
|
129K
$5.33M
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-93.8K- 38.69% |
$1.72M - $3.2M
|
149K
$6.15M
|
|
|
Feb 14, 2024
Q4 2023
|
Sectoral Asset Management Inc
Montreal, A8 |
SELL
|
- |
-129K- 90.39% |
$2.37M - $4.4M
|
13.7K
$567K
|
|
|
Feb 14, 2024
Q4 2023
|
Twinbeech Capital LP
Purchase, NY |
SELL
|
- |
-179K- 95.98% |
$3.28M - $6.1M
|
7.49K
$309K
|
|
|
Feb 14, 2024
Q4 2023
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-185K- 5.89% |
$3.4M - $6.33M
|
2.96M
$122M
|
|
|
Feb 13, 2024
Q4 2023
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-193K- 88.32% |
$3.54M - $6.58M
|
25.5K
$1.05M
|
|
|
Feb 14, 2024
Q4 2023
|
Integral Health Asset Management, LLC
|
SELL
|
- |
-325K- 61.9% |
$5.96M - $11.1M
|
200K
$8.27M
|
|
|
Feb 14, 2024
Q4 2023
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-396K- 41.09% |
$7.26M - $13.5M
|
567K
$23.4M
|
|
|
Feb 14, 2024
Q4 2023
|
Boxer Capital, LLC
San Diego, CA |
SELL
|
- |
-405K- 8.64% |
$7.43M - $13.8M
|
4.28M
$177M
|
|
|
Feb 14, 2024
Q4 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-458K- 9.0% |
$8.41M - $15.6M
|
4.64M
$192M
|
|
|
Feb 14, 2024
Q4 2023
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-503K- 38.05% |
$9.23M - $17.2M
|
819K
$33.9M
|
|
|
Feb 14, 2024
Q4 2023
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-597K- 90.87% |
$11M - $20.4M
|
60K
$2.48M
|
|
|
Feb 14, 2024
Q4 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-694K- 93.15% |
$12.7M - $23.7M
|
51.1K
$2.11M
|
|
|
Feb 09, 2024
Q4 2023
|
Artal Group S.A.
Luxembourg, N4 |
SELL
|
- |
-834K- 32.96% |
$15.3M - $28.4M
|
1.7M
$70.1M
|
|
|
Feb 09, 2024
Q4 2023
|
Column Group LLC
San Francisco, CA |
SELL
|
- |
-1.23M- 100.0% |
$22.6M - $42M
|
46
$1.9K
|
|
|
Feb 14, 2024
Q4 2023
|
Eco R1 Capital, LLC
San Francisco, CA |
SELL
|
- |
-5.45M- 97.62% |
$99.9M - $186M
|
133K
$5.48M
|